Health Care & Life Sciences » Pharmaceuticals | Kyongbo Pharmaceutical Co. Ltd.

Kyongbo Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
162,218
169,781
178,033
186,726
191,661
201,344
Cost of Goods Sold (COGS) incl. D&A
111,397
119,976
130,325
141,777
136,022
150,079
Gross Income
50,821
49,805
47,708
44,949
55,639
51,264
SG&A Expense
24,607
22,137
22,075
29,355
31,052
33,998
EBIT
26,214
27,669
25,632
15,594
24,587
17,267
Unusual Expense
-
-
226
52
-
102
Non Operating Income/Expense
1,370
3,505
1,000
955
676
1,162
Interest Expense
1,903
1,229
878
960
1,005
889
Pretax Income
23,121
30,034
25,532
15,643
24,261
17,644
Income Tax
5,096
21,398
577
2,937
6,298
4,527
Consolidated Net Income
18,025
8,636
26,110
12,706
17,963
13,116
Net Income
18,025
8,636
26,110
12,706
17,963
13,116
Net Income After Extraordinaries
18,025
8,636
26,110
12,706
17,963
13,116
Net Income Available to Common
18,025
8,636
26,110
12,706
17,963
13,116
EPS (Basic)
754.00
361.00
1,147.00
531.00
751.00
548.63
Basic Shares Outstanding
24
24
23
24
24
24
EPS (Diluted)
753.96
361.23
1,146.81
531.48
751.39
548.63
Diluted Shares Outstanding
24
24
23
24
24
24
EBITDA
-
-
33,911
26,034
36,054
28,824
Non-Operating Interest Income
181
90
4
3
3
2

About Kyongbo Pharmaceutical Co.

View Profile
Address
174 Sirok-ro
Asan SC 31501
Korea, Republic Of
Employees -
Website http://www.kbpharma.co.kr
Updated 07/08/2019
KYONGBO PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of pharmaceutical products. Its products include general, antibiotic, anticancer active pharmaceutical ingredients, inhalation anesthetic, cefaclor capsule and cefaclor dried syrup. The company was founded on March 31, 1987 and is headquartered in Asan, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.